Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 1 filers reported holding Santen Pharmaceutical Co Ltd in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | -50.0% | 199 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 199 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -33.3% | 199 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | 0.0% | 199 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 199 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | 0.0% | 199 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $3,000 | – | 199 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHUMBLINE ADVISERS | 30 | $273 | 0.00% |